Cancer stem cell targeted therapy: progress amid controversies
Metrics: PDF 2491 views | HTML 2951 views | ?
Tao Wang1,2, Sarah Shigdar2, Michael P. Gantier3,4 , Yingchun Hou5, Li Wang6, Yong Li7, Hadi Al Shamaileh2, Wang Yin2, Shu-Feng Zhou8, Xinhan Zhao9 and Wei Duan2
1 School of Nursing, Zhengzhou University, Zhengzhou, China
2 School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia
3 Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia
4 Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia
5 Co-Innovation Center for Qinba Region’s Sustainable Development, Shaanxi Normal University, Xi’an, China
6 Department of Gynecologic Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
7 Cancer Care Centre, St George Hospital and St George Clinical School, University of New South Wales (UNSW), Kensington, Australia
8 Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA
9 Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University School of Medicine, Xi’an, China
Xinhan Zhao, email:
Wei Duan, email:
Keywords: cancer, cancer stem cell, anti-cancer treatment, cancer stem cell marker, cancer stem cell model
Received: August 12, 2015 Accepted: October 06, 2015 Published: October 19, 2015
Although cancer stem cells have been well characterized in numerous malignancies, the fundamental characteristics of this group of cells, however, have been challenged by some recent observations: cancer stem cells may not necessary to be rare within tumors; cancer stem cells and non-cancer stem cells may undergo reversible phenotypic changes; and the cancer stem cells phenotype can vary substantially between patients. Here the current status and progresses of cancer stem cells theory is illustrated and via providing a panoramic view of cancer therapy, we addressed the recent controversies regarding the feasibility of cancer stem cells targeted anti-cancer therapy.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.